Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML
Joerg U Schmohl, Tina Nuebling, Julia Wild, Tanja Kroell, Lothar Kanz, Helmut R Salih, Helga Schmetzer
DOI: 10.1136/jim-2016-000081 Published 23 November 2016
Joerg U Schmohl
1Section of Molecular Cancer Therapeutics, Therapeutic Radiology-Radiation Oncology, University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, USA
2Department of Hematology and Oncology, Medical Department 2, University Hospital of Tuebingen, Tuebingen, Germany
Tina Nuebling
2Department of Hematology and Oncology, Medical Department 2, University Hospital of Tuebingen, Tuebingen, Germany
3Clinical Collaboration Unit Translational Immunology, Department for Internal Medicine II, German Cancer Consortium and German Cancer Research Center, Partner site Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany
Julia Wild
2Department of Hematology and Oncology, Medical Department 2, University Hospital of Tuebingen, Tuebingen, Germany
3Clinical Collaboration Unit Translational Immunology, Department for Internal Medicine II, German Cancer Consortium and German Cancer Research Center, Partner site Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany
Tanja Kroell
4Department for Hematopoetic Cell Transplantation, Medical Department 3, University Hospital of Munich, Munich, Germany
Lothar Kanz
2Department of Hematology and Oncology, Medical Department 2, University Hospital of Tuebingen, Tuebingen, Germany
Helmut R Salih
2Department of Hematology and Oncology, Medical Department 2, University Hospital of Tuebingen, Tuebingen, Germany
3Clinical Collaboration Unit Translational Immunology, Department for Internal Medicine II, German Cancer Consortium and German Cancer Research Center, Partner site Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany
Helga Schmetzer
4Department for Hematopoetic Cell Transplantation, Medical Department 3, University Hospital of Munich, Munich, Germany
Submit a Response to This Article
No eLetters have been published for this article.
Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML
Joerg U Schmohl, Tina Nuebling, Julia Wild, Tanja Kroell, Lothar Kanz, Helmut R Salih, Helga Schmetzer
Journal of Investigative Medicine Dec 2016, 64 (8) 1252-1260; DOI: 10.1136/jim-2016-000081
Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML
Joerg U Schmohl, Tina Nuebling, Julia Wild, Tanja Kroell, Lothar Kanz, Helmut R Salih, Helga Schmetzer
Journal of Investigative Medicine Dec 2016, 64 (8) 1252-1260; DOI: 10.1136/jim-2016-000081